Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07570147
PHASE1

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

The objective of this study is to assess the pharmacokinetic (PK), immunogenicity, safety, and tolerability of ABBV-1451 after single ascending doses in healthy adult volunteers.

Official title: A First in Human, Single Ascending Dose Study of ABBV-1451 to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability in Healthy Subjects and in Japanese and Han Chinese Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-04-28

Completion Date

2027-04

Last Updated

2026-05-06

Healthy Volunteers

Yes

Interventions

DRUG

ABBV-1451

Injection

DRUG

ABBV-1451

Infusion

OTHER

Placebo

Injection

OTHER

Placebo

Infusion

Locations (1)

Acpru /Id# 282128

Grayslake, Illinois, United States